Inactive Instrument

Auspex Pharmaceuticals Inc Share Price

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2015	Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions	RE
2015	Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal	RE

Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions	22/15/22	RE
Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal	22/15/22	RE
Stocks rally on merger activity; dollar gains	31/15/31	RE
Stocks rally on merger activity; dollar gains	31/15/31	RE
FUJIFILM : Wall St. rebounds from recent losses; deals help	31/15/31	RE
Auspex Pharmaceuticals : Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion	30/15/30	RE

Auspex Pharmaceuticals : Ryan & Maniskas, LLP : Announces Investigation of Auspex Pharmaceuticals, Inc.	31/15/31	PR
Auspex Pharmaceuticals : Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Auspex Pharmaceuticals, Inc. Stockholders	31/15/31	BU
Auspex Pharmaceuticals : Pharma Stockholders Encouraged to Contact Securities Law Firm about Takeover	31/15/31	PR
Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting	27/15/27	GL
Auspex Pharmaceuticals Reports Fourth Quarter 2014 Results and Business Highlights	17/15/17	GL

Wall Street rebondit avec les fusions-acquisitions	31/15/31
FUJIFILM : Wall Street ouvre en hausse avec les fusions-acquisitions	30/15/30
Auspex Pharmaceuticals : Teva rachète l'américain Auspex pour 3,5 milliards de dollars	30/15/30
Adamis Pharmaceuticals : Les valeurs à suivre sur les marchés américains	30/15/30

Managers	Title	Age	Since
Brendan O'Grady CEO	Chief Executive Officer	57	-

Members of the board	Title	Age	Since
Rod A. Ferguson BRD	Director/Board Member	67	01/13/01
Alex Zisson BRD	Director/Board Member	54	17/13/17
Sep Sarshar FOU	Founder	57	28/01/28

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2.72%	103B
REGENERON PHARMACEUTICALS, INC.	+1.40%	95.28B
ARGENX SE	+1.46%	22.15B
BIONTECH SE	-15.90%	21.02B
GENMAB A/S	-8.58%	18.15B
WUXI APPTEC CO., LTD.	-38.74%	16.73B
BEIGENE, LTD.	-13.01%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+5.03%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.36%	12.17B